Radiopharmaceuticals in Nuclear Medicine Market driven by Rising Prevalence of Cardiovascular and Oncological Diseases
The Global Radiopharmaceuticals in Nuclear Medicine Market is estimated to be valued at US$ 7.10 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031.
Radiopharmaceuticals in Nuclear Medicine Market Growth is prevalence of cancer and cardiac diseases has increased the demand for early diagnostics using nuclear medicine techniques. Radiopharmaceuticals provide non-invasive disease characterization and targeted molecular imaging. This has boosted their use in diagnosis and treatment monitoring.
Get more insights on, Radiopharmaceuticals in Nuclear Medicine Market (https://justpaste.me/KxRz3)
#coherentmarketinsights #increasinggeriatricpopulation #stringentregulatoryframeworks #supplychainchallenges #growingapplicationsintheragnostics
